Boston Scientific Corp (BSX)

Total asset turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue (ttm)	US$ in thousands	16,746,000	15,910,000	15,228,000	14,707,000	14,240,000	13,757,000	13,400,000	13,045,000	12,682,000	12,567,000	12,329,000	12,162,000	11,888,000	11,469,000	11,196,000	10,122,000	9,913,000	10,110,000	10,158,000	10,786,000
Total assets	US$ in thousands	39,395,000	38,078,000	37,108,000	36,669,000	35,136,000	34,043,000	33,601,000	32,892,000	32,470,000	31,948,000	32,190,000	32,337,000	32,230,000	31,877,000	31,168,000	30,900,000	30,778,000	30,845,000	30,823,000	30,113,000
Total asset turnover		0.43	0.42	0.41	0.40	0.41	0.40	0.40	0.40	0.39	0.39	0.38	0.38	0.37	0.36	0.36	0.33	0.32	0.33	0.33	0.36

December 31, 2024 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $16,746,000K ÷ $39,395,000K
= 0.43

Boston Scientific Corp's total asset turnover has been gradually increasing over the past few years, indicating an improvement in the company's efficiency in generating sales relative to its total assets. The ratio has moved from 0.36 in March 2020 to 0.43 in December 2024, with a consistent upward trend. This suggests that Boston Scientific Corp has been effectively utilizing its assets to generate revenue. A higher total asset turnover ratio generally implies better efficiency in resource utilization and potentially higher profitability. It indicates that the company is efficiently generating sales relative to the size of its asset base, which is a positive sign for investors and stakeholders.